Ramsay Sime Darby Health Shortlists Bidders for Over $1.0 Billion Deal

[ad_1] Updated Nov. 1, 2023 10:41 pm ET TPG-backed hospital operator Columbia Asia and a consortium led by Affinity Partners have emerged as the two shortlisted bidders for buying Asia-focused…

Kaiser Permanente, Unions Reach Deal on New Contracts

[ad_1] Kaiser Permanente and labor unions reached a tentative agreement to resolve a contentious contract dispute that sent workers to picket lines earlier this month.  Copyright ©2023 Dow Jones &…

Healthcare Strikes Threaten to Prolong Wage Pressure on Hospitals

[ad_1] Tenet could face labor action next, after Kaiser Permanente workers staged the largest U.S. healthcare walkout on record. [ad_2] Source link

Striking Healthcare Workers Return to Work—Without New Contracts

[ad_1] Talks between Kaiser Permanente and unions are scheduled to resume Thursday, after employees temporarily walked off. [ad_2] Source link

Kaiser Permanente Union Workers Strike, Mounting Largest U.S. Healthcare Walkout on Record

[ad_1] More than 75,000 nurses, pharmacists and other employees have stopped work in a dispute over wages and staffing. [ad_2] Source link

Kaiser Permanente Unions Strike, Mounting Largest U.S. Healthcare Walkout in Decades

[ad_1] More than 75,000 nurses, pharmacists and other employees have stopped work in a dispute over wages and staffing. [ad_2] Source link

Blockbuster Cancer Treatment Stymied by Supply Chain—for Now

[ad_1] A cell therapy for multiple myeloma promises to be a major blockbuster for J&J and partner Legend, if they can increase manufacturing. [ad_2] Source link

WSJ News Exclusive | Cracks Deepen for America’s Biggest Hospital Landlord: Struggling Tenants, a Bailout on Hold

[ad_1] A California regulator has halted a plan for Medical Properties Trust to take a stake in a struggling hospital chain’s business. [ad_2] Source link

Fresenius Earnings Falls on Rising Costs

[ad_1] Fresenius posted lower profits for the second quarter due to rising costs, higher taxes and negative developments at its hospital subsidiary, but its dialysis business posted positive results, with…

New Gene Therapy Could Face Uphill Battle Despite FDA Approval

[ad_1] The FDA approval of BioMarin’s gene therapy for hemophilia is a major win, but patient uptake could be slow. [ad_2] Source link